Rahsaan W. Thompson

Rahsaan W. Thompson

Chief Legal Officer, Secretary and Compliance OfficeratZevra Therapeutics· In the 2025 proxy

Pay in FY2025Zevra Therapeutics stock +7.4% the same year

Rahsaan W. Thompson was paid $1.6M in FY2025 (Dec). Zevra Therapeutics stock rose 7.4% that year.

Pay$100 in the stock at the end of FY24 → $107
Pay is from the Summary Compensation Table of each Zevra Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zevra TherapeuticsPublic company · 1 yr
    • Chief Legal Officer, Secretary and Compliance Officer2025 – Present · 1 yrStock in role +20%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?